RA Capital Management »

Alx Oncology Hldgs shares owned by RA Capital Management

Quarter-by-quarter ownership of Alx Oncology Hldgs (ALXO) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 13M 2.01

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Alx Oncology Hldgs

RA Capital Management
TCG Crossover Management
venBio Partners
Redmile Group
Blackstone Group
Vanguard Capital Management
Vivo Capital
Almitas Capital
5AM Venture Management
OrbiMed Advisors
Millennium Management
Vanguard Group
Two Sigma Investments
Squadron Capital Management
Driehaus Capital Management

View all funds holding Alx Oncology Hldgs